Trial Profile
Population pharmacokinetics and exposure–neutropenia relationship of nab-paclitaxel in patients with solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 31 Aug 2015 New trial record